Analytical Data
-
基因名
CPA1
- Application
-
别名
CPA1；CPA；Carboxypeptidase A1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P15085
-
表达区间
17-419aa
-
氨基酸序列
KEDFVGHQVLRISVADEAQVQKVKELEDLEHLQLDFWRGPAHPGSPIDVR VPFPSIQAVKIFLESHGISYETMIEDVQSLLDEEQEQMFAFRSRARSTDT FNYATYHTLEEIYDFLDLLVAENPHLVSKIQIGNTYEGRPIYVLKFSTGG SKRPAIWIDTGIHSREWVTQASGVWFAKKITQDYGQDAAFTAILDTLDIF LEIVTNPDGFAFTHSTNRMWRKTRSHTAGSLCIGVDPNRNWDAGFGLSGA SSNPCSETYRGKFANSEVEVKSIVDFVKDHGNIKAFISIHSYSQLLMYPY GYKTEPVPDQDELDQLSKAAVTALASLYGTKFNYGSIIKAIYQASGSTID WTYSQGIKYSFTFELRDTGRYGFLLPASQIIPTAKETWLALLTIMEHTLN HPYVDHHHHHH
-
分子量
47 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CPA1, or carboxypeptidase A1, is a digestive enzyme predominantly secreted by the pancreas that plays a crucial role in the final stages of protein digestion. The study of CPA1 and its recombinant forms has gained significant attention due to its potential applications in both basic research and therapeutic development. Understanding the structure and function of CPA1 can provide insights into enzymatic mechanisms, protein processing, and the regulation of digestive pathways. In pathological conditions, such as pancreatic disorders, the activity and expression of CPA1 might be altered, leading to digestive challenges and other health complications. The recombinant production of CPA1 allows researchers to study its properties in detail, explore its substrate specificity, and assess its interactions with inhibitors and activators. Furthermore, recombinant CPA1 can serve as a valuable tool in protein engineering and biotechnology, aiding the development of novel therapeutics or diagnostic tools. The ability to produce this enzyme in a controlled manner opens avenues for investigating its role in various biological systems and could lead to industrial applications where CPA1 is utilized for protein processing or biocatalysis. Thus, the research on CPA1 not only contributes to a deeper understanding of digestive biology but also holds promise for advancing medical and biotechnological innovations.
